E-Articles - Health and Fitness

Since the Democrats have taken control of the House, the word around town is that Nanci

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

Pelosi is going to shake things up. First on her itinerary, to allow Medicare to negoti

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

ate with drug manufactures the price of it purchases its prescription medication. Altho

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ugh this should bring the cost of Medicare down, will this lofty goal ever materialize?

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

Recently, the United States House of Representatives passed a bill with a vote of 255 t

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

170. If that bill becomes a law, this would allow drug prices to be negotiated by the

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

Secretary of Health and Human Services.

Opponents of the bill argue that interference w

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ith the current system will decrease the amount of competition in the market, driving cu

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

rrent prices even higher.

While both sides battle it out, the consumers are stuck in th

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

e middle, destined to pay the high, ever-increasing cost of prescription drugs that is

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ising at more than double the rate of inflation.

Will the bill make it through and take

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

away the high cost healthcare burden placed upon senior citizens and the beneficiaries

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

of Medicare? No. Odds are the bill will not make it passed the veto promised by the pr

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

esident. As goedwardsville.com points out, “we hope it will at least allow (not necessa

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

rily mandate) for price negotiation on the part of the federal government, in the event

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

rivate insurers and manufacturers fail the public's trust and prices continue to skyrock

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

et.”

goedwardsville.com also points out that a recent Kaiser report states that 80 perc

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ent of Americans favor allowing price negotiations with prescription drug manufacturers

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

in order to drive down the cost of Medicare.

For more information on ordering from an o

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

nline foreign pharmacy

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-article.org.ua/article/251988/e-article-Will-Drug-Price-Negotiations-Really-Ever-Occur.html">Will Drug Price Negotiations Really Ever Occur?</a>

BB link (for phorums):
[url=http://www.e-article.org.ua/article/251988/e-article-Will-Drug-Price-Negotiations-Really-Ever-Occur.html]Will Drug Price Negotiations Really Ever Occur?[/url]

Internet advertising can bring you headaches as well as riches. One of the issues we all have to deal with is the constant steam of unsolicited email. This article will reveal a few inexpensive ways to cut down the flow of this persistent, often time consuming nuisance. The earlier you implement these little known secrets the better off you will be.

Giving away content is a powerful way to get free advertising. For example, give other people permission to use your article on their web site or in their e-zine. The resource box at the end of your article acts as an ad. In return, you get free advertising. It's a win/win situation for both you and the people that need the extra content.

Adequate preparation for the IIM GD process involves having a list of topics and ready made startegies based on economic concepts for constant practice and then doing mock Group Discussion and Personal Interviews to get a feel of the actual GD/PI

Tags

Links

E-Articles - Will Drug Price Negotiations Really Ever Occur?

Related Articles: